Login
 
Forgotten password
Sitemap Contact

Management

CEO
Nicolas Durand

Way to success Story

Abionic has developed a device for rapid and reliable allergy tests. Currently, the young company...Read more on swissventureguide.ch

Contact Info

Abionic SA
EPFL Innovation Park, B√Ętiment B
1015  Lausanne
Switzerland
www.abionic.com

Google Map

Abionic SA

«Nanotechnology for allergy experts»

Presented by CTI Invest on 15.12.2010

Abionic is a start-up based in Switzerland, strongly positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses the most advanced technology to offer the medical profession a novel point-of-care diagnostic tool which is designed to provide patients with personal allergy profiles.

Investor: BlueOcean Ventures
Founded 2010
Industry Medtech
Nanotechnology
Biotechnology
Status looking for investor


Awards

Contact CTI Invest

Jean-Pierre Vuilleumier
Managing Director
P: +41 79 251 32 09